NCT02203565View on ClinicalTrials.gov

Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 7, 2016

Study Completion Date

July 7, 2016

Conditions
Breast CancerSkin Reactions Secondary to Radiation Therapy
Interventions
DRUG

Dakin's solution

Applied topically

RADIATION

radiation therapy

Undergo radiation therapy

OTHER

questionnaire administration

Ancillary studies

OTHER

laboratory biomarker analysis

Optional correlative studies

Trial Locations (1)

94305

Stanford University, School of Medicine, Stanford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT02203565 - Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy | Biotech Hunter | Biotech Hunter